| Clinicopathological relevance of BRAF mutations in human cancer S Pakneshan, A Salajegheh, RA Smith, AKY Lam Pathology-Journal of the RCPA 45 (4), 346-356, 2013 | 187 | 2013 |
| Integration of traditional and e‐learning methods to improve learning outcomes for dental students in histopathology A Ariana, M Amin, S Pakneshan, E Dolan-Evans, AK Lam Journal of dental education 80 (9), 1140-1148, 2016 | 95 | 2016 |
| Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists A Salajegheh, EB Petcu, RA Smith, AKY Lam Postgraduate medical journal 84 (988), 78-82, 2008 | 88 | 2008 |
| Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant RA Smith, A Salajegheh, S Weinstein, M Nassiri, AK Lam Human pathology 42 (4), 500-506, 2011 | 82 | 2011 |
| Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes A Salajegheh, RA Smith, K Kasem, V Gopalan, MR Nassiri, R William, ... European Journal of Surgical Oncology (EJSO) 37 (1), 93-99, 2011 | 82 | 2011 |
| B-Raf mutation: a key player in molecular biology of cancer MA Rahman, A Salajegheh, RA Smith, AKY Lam Experimental and molecular pathology 95 (3), 336-342, 2013 | 81 | 2013 |
| A review of the profile of endothelin axis in cancer and its management S Irani, A Salajegheh, RA Smith, AKY Lam Critical reviews in oncology/hematology 89 (2), 314-321, 2014 | 69 | 2014 |
| Co-regulatory potential of vascular endothelial growth factor–A and vascular endothelial growth factor–C in thyroid carcinoma A Salajegheh, S Pakneshan, A Rahman, E Dolan-Evans, S Zhang, ... Human pathology 44 (10), 2204-2212, 2013 | 66 | 2013 |
| Regulation of microRNA‐1288 in colorectal cancer: Altered expression and its clinicopathological significance V Gopalan, S Pillai, F Ebrahimi, A Salajegheh, TC Lam, TK Le, ... Molecular carcinogenesis 53 (S1), E36-E44, 2014 | 65 | 2014 |
| miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma H Vosgha, A Ariana, RA Smith, AK Lam Endocrine-related cancer 25 (3), 323-337, 2018 | 55 | 2018 |
| The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression A Salajegheh, E Dolan-Evans, E Sullivan, S Irani, MA Rahman, H Vosgha, ... Experimental and molecular pathology 96 (2), 212-218, 2014 | 53 | 2014 |
| BRAF inhibitors: from the laboratory to clinical trials MA Rahman, A Salajegheh, RA Smith, AKY Lam Critical reviews in oncology/hematology 90 (3), 220-232, 2014 | 52 | 2014 |
| The roles of JK-1 (FAM134B) expressions in colorectal cancer K Kasem, V Gopalan, A Salajegheh, CT Lu, RA Smith, AKY Lam Experimental cell research 326 (1), 166-173, 2014 | 49 | 2014 |
| BRAF inhibitor therapy for melanoma, thyroid and colorectal cancers: development of resistance and future prospects M Atiqur Rahman, A Salajegheh, R Anthony Smith, K Lam Current cancer drug targets 14 (2), 128-143, 2014 | 44 | 2014 |
| JK1 (FAM134B) represses cell migration in colon cancer: a functional study of a novel gene K Kasem, E Sullivan, V Gopalan, A Salajegheh, RA Smith, AKY Lam Experimental and Molecular Pathology 97 (1), 99-104, 2014 | 34 | 2014 |
| JK1 (FAM134B) gene and colorectal cancer: a pilot study on the gene copy number alterations and correlations with clinicopathological parameters K Kasem, V Gopalan, A Salajegheh, CT Lu, RA Smith, AKY Lam Experimental and Molecular Pathology 97 (1), 31-36, 2014 | 30 | 2014 |
| Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics S Irani, A Salajegheh, V Gopalan, RA Smith, AKY Lam Annals of diagnostic pathology 18 (2), 43-48, 2014 | 30 | 2014 |
| GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features V Gopalan, RA Smith, MR Nassiri, K Yasuda, A Salajegheh, SY Kim, ... Human pathology 41 (7), 1009-1015, 2010 | 29 | 2010 |
| Interactions of vascular endothelial growth factor and p53 with miR-195 in thyroid carcinoma: possible therapeutic targets in aggressive thyroid cancers H Maroof, S Irani, A Arianna, J Vider, V Gopalan, AK Lam Current cancer drug targets 19 (7), 561-570, 2019 | 23 | 2019 |
| The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma H Maroof, F Islam, A Ariana, V Gopalan, AK Lam Endocrine 58, 153-166, 2017 | 22 | 2017 |
Alfred LamProfessor of Pathology, Griffith UniversityVerified email at griffith.edu.au
